Chikungunya fever is a viral illness transmitted by mosquitoes. The name translates to "bends you up" or "stooped walk" due ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

In cases of acute arthritis, it is crucial to consider infectious causes, particularly viral infections. This recommendation ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Valneva will work with local health authorities and wholesalers on the French island territory to distribute the vaccines.

Roorkee researchers have identified a new potential treatment for Chinkungunya, indicate that Efavirenz, a widely used HIV ...

Efavirenz (EFV), brand-named drugs such as Sustiva, is an antiretroviral drug utilized mostly for HIV/AIDS treatment and prevention. Efavirenz is a category of drugs that fall under non-nucleoside ...

Chikungunya is a mosquito-borne viral disease. The illness is marked by fever, severe joint pain, and muscle aches, and currently has no specific antiviral treatment. According to a the Centers ...

The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

As per the findings, Efavirenz, a drug widely used for HIV treatment, may serve as an effective therapy for Chikungunya disease, as it has been shown to reduce Chikungunya virus replication both ...